Hikal Limited

Web: hikal.com NSE: HIKAL BSE: 524735 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

211 3(-1%)

Volume

9L as on 23, Jun

Open

367

High

376

Low

366

214

VWAP

219

52 Week High

355

52 Week Low

146

Viand Research Rating

Quality Score

2/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,603

No. of Shares

12.3

P/E

64.82

P/B

4.01

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

6.18

ROCE

Profit Growth

Listing Date

14-Feb-01

Promoter Holding

68.85%

FII Holding

1.44%

DII Holding

7.2%

Price Chart

Price Performance

1 Week15%

1 Month6%

3 Months39%

6 Months20%

1 Year20%

YTD20%

Moving Average

5 Day SMA206

10 Day SMA194

20 Day SMA195

30 Day SMA198

50 Day SMA196

61 Day SMA190

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	245	224	234	243
Resistance 2	234	222	227	233
Resistance 1	226	220	223	224
Pivot Point	216	219	216	215
Support 1	208	217	208	206
Support 2	197	215	204	196
Support 3	189	213	197	187

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.85%	(0.01) 68.82%	(0.01) 68.77%	(0.01) 68.77%	(0.01) 68.77%	(0.01) 68.77%	(0.01) 68.77%
FIIs	(-0.91) 1.44%	(-1.91) 2.31%	(-1.11) 4.23%	(-0.41) 5.35%	(-0.41) 5.70%	(-0.71) 6.06%	(0.11) 6.78%	(0.11) 6.66%	(0.41) 6.55%	(1.31) 6.14%	(0.21) 4.81%	(0.01) 4.57%	(0.21) 4.56%	(0.11) 4.40%	(0.41) 4.27%	(-3.01) 3.91%	(0.01) 6.92%	(0.61) 6.91%	(0.01) 6.36%
DIIs	(0.21) 7.20%	(1.91) 7.05%	(1.11) 5.15%	(0.21) 4.03%	(0.31) 3.80%	(-0.11) 3.48%	(0.41) 3.58%	(-0.41) 3.17%	(0.41) 3.53%	(0.01) 3.15%	(0.31) 3.11%	(0.61) 2.78%	(0.61) 2.18%	(0.21) 1.57%	(0.51) 1.37%	(0.01) 0.89%	(0.51) 0.89%	(-0.21) 0.39%	(0.01) 0.59%
Public	22.51%	21.78%	21.75%	21.76%	21.65%	21.61%	20.79%	21.32%	21.06%	21.85%	23.22%	23.79%	24.40%	25.20%	25.58%	26.43%	23.42%	23.93%	24.28%
No. of Shareholders	74,270	74,117	73,404	71,391	68,907	71,801	71,912	70,978	71,840	74,657	76,126	75,110	75,167	75,780	78,500	79,105	75,341	72,450	68,233

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	519	494	318	380	552	448	453	407	514	448	435	388	545	540.2	559	379	502	515	469	456.78
Sales Growth % (YoY)	-6%	10.4%	-29.7%	-6.5%	7.4%	0%	4.1%	4.8%	-5.7%	-17.2%	-22.2%	2.4%	8.6%	5%	19.1%	-17.1%	-5.6%	11.1%	26.1%	29.5%
Sales Growth % (QoQ)	5.1%	55.3%	-16.3%	-31.2%	23.2%	-1.1%	11.3%	-20.8%	14.7%	3%	12.1%	-28.8%	0.9%	-3.4%	47.5%	-24.5%	-2.5%	9.8%	2.7%	-
Expenses	414	412	311	355	429	376	378	349	420	383	377	338	457	465.62	489	356	441	422	378	361.02
Operating Profit	105	83	7	25	123	72	75	58	94	65	58	50	88	74.58	70	23	61	93	91	95.76
OPM %	20	17	2	7	22	16	17	14	18	14	13	13	16	13.81	12	6	12	18	19	20.96
Other Income	-40	-35	2	1	0	4	0	0	0	0	1	1	0	2.51	1	3	0	1	1	3.18
Interest	15	16	15	17	18	19	19	20	15	14	13	14	13	13.03	11	11	8	7	8	7.99
Depreciation	42	41	41	39	38	33	32	32	32	29	29	28	27	28.27	27	26	24	25	24	22.56
Profit before tax	8	-9	-47	-30	68	24	25	7	47	22	17	10	49	35.79	33	-12	29	62	60	68.39
Tax %	-73	-36	-26	-26	26	28	26	26	28	25	25	29	26	26.21	24	-25	28	27	26	26.1
Net Profit	14	-6	-35	-22	50	17	18	5	34	16	13	7	36	26.41	25	-9	21	45	44	50.54
Net Profit Growth % (QoQ)	333.3%	82.9%	-59.1%	-144%	194.1%	-5.6%	260%	-85.3%	112.5%	23.1%	85.7%	-80.6%	36.3%	5.6%	377.8%	-142.9%	-53.3%	2.3%	-12.9%	-
Net Profit Growth % (YoY)	-72%	-135.3%	-294.4%	-540%	47.1%	6.2%	38.5%	-28.6%	-5.6%	-39.4%	-48%	177.8%	71.4%	-41.3%	-43.2%	-117.8%	-	-	-	-
TTM Net Profit	-49	-13	10	63	90	74	73	68	70	72	82.41	94.41	78.41	63.41	82	101	160.54	139.54	94.54	0
EPS in Rs	1.17	-0.48	-2.83	-1.82	4.07	1.39	1.48	0.41	2.75	1.31	1.02	0.56	2.92	2.14	2.01	-0.72	1.68	3.67	3.57	4.1

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1713	1860	1785	2023	1943	1720	1507	1590	1296	1014	926	872	829	660
Sales Growth %	-7.9%	4.2%	-11.8%	4.1%	12.9%	14.1%	-5.2%	22.6%	27.8%	9.5%	6.2%	5.1%	25.6%	-6.7%
Expenses	1492	1531	1518	1765	1602	1398	1234	1291	1054	813	745	689	642	476
Operating Profit	220	328	267	258	341	323	273	298	242	201	181	182	187	184
OPM %	13	18	15	13	18	19	18	19	19	20	20	21	23	28
Other Income	-73	5	2	5	5	5	-12	2	4	-3	2	2	34	-42
Interest	62	75	56	48	31	36	52	58	49	48	62	60	68	60
Depreciation	164	134	118	109	96	85	82	93	86	69	67	64	55	49
Profit before tax	-78	124	96	105	219	206	127	149	112	80	53	60	98	33
Tax %	-38	27	27	26	27	36	33	31	31	16	23	32	35	24
Net Profit	-49	91	70	78	160	133	84	103	77	68	41	40	64	25
Net Profit Growth %	-153.8%	30%	-10.3%	-51.2%	20.3%	58.3%	-18.4%	33.8%	13.2%	65.9%	2.5%	-37.5%	156%	-
EPS in Rs	-3.96	7.36	5.64	6.36	13.02	10.8	6.85	8.36	6.26	5.49	3.34	3.28	5.17	2.04
Dividend Payout %	-15	11	21	19	12	19	18	14	13	15	20	20	12	16

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	302	280	187	315	294	229	285	186	139	163	186	102	154	61
Cash from Investing Activity	-145	-136	-174	-292	-284	-156	-164	-125	-110	-102	-64	-43	-23	-28
Cash from Financing Activity	-160	-144	-27	-8	-6	-97	-101	-55	-25	-63	-124	-69	-124	-27
Net Cash Flow	-3	0	-14	15	4	-24	20	6	4	-2	-2	-10	7	6

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	25	25	25	25	25	25	25	25	25	25	16	16	16	16	16	16
Reserves	1174	1170	1238	1179	1163	1109	1043	909	792	732	653	589	547	516	488	434
Borrowings	684	683	765	775	818	748	675	610	646	661	635	598	505	547	546	584
Other Liabilities	483	472	502	482	482	504	470	370	306	268	237	177	206	212	219	157
Total Liabilities	2365	2349	2529	2460	2487	2385	2213	1913	1768	1686	1542	1379	1275	1292	1270	1191
Fixed Assets	1333	1340	1364	1038	1071	948	879	713	735	713	634	668	623	639	644	660
CWIP	94	134	121	438	414	412	295	254	161	79	118	63	66	62	61	49
Investments	10	10	10	17	5	5	11	1	1	1	3	4	3	3	3	3
Other Assets	928	865	1034	967	997	1020	1028	946	871	893	788	645	583	588	562	479
Total Assets	2365	2349	2529	2460	2487	2385	2213	1913	1768	1686	1542	1379	1275	1292	1270	1191

Delivery

#	Date	175 44% 253	Value (Cr)	Q/T 61	Del 38	Del 14
1	22-Jul	214	9	55	52	4
2	21-Jul	225	10	52	45	5
3	20-Jul	227	7	46	33	2
4	17-Jul	229	5	47	45	2
5	16-Jul	234	10	55	43	4
6	15-Jul	241	15	56	29	4
7	14-Jul	237	9	49	42	4
8	13-Jul	246	32	72	29	10
9	10-Jul	245	38	78	32	12
10	9-Jul	234	41	77	24	10
11	8-Jul	229	241	80	11	27
12	7-Jul	217	3	40	46	1
13	6-Jul	220	4	50	56	2
14	3-Jul	222	3	37	51	1
15	2-Jul	223	6	51	49	3
16	1-Jul	219	8	51	49	4
17	30-Jun	221	12	61	37	5
18	29-Jun	215	4	52	43	2
19	25-Jun	215	6	51	43	2
20	24-Jun	218	8	62	39	3
21	23-Jun	218	21	73	36	7
22	22-Jun	219	28	80	31	9
23	19-Jun	205	15	73	37	6
24	18-Jun	199	17	93	34	6
25	17-Jun	190	3	80	64	2
26	16-Jun	190	5	66	46	2
27	15-Jun	187	6	75	30	2
28	12-Jun	184	3	48	47	1
29	11-Jun	176	2	46	41	1
30	10-Jun	178	3	61	56	2
31	9-Jun	181	3	56	51	2
32	8-Jun	180	5	61	51	2
33	5-Jun	190	3	76	49	2
34	4-Jun	192	4	66	44	2
35	3-Jun	188	2	47	46	1
36	2-Jun	191	3	51	47	2
37	1-Jun	192	5	45	37	2
38	29-May	195	23	71	47	11
39	27-May	221	23	80	40	9
40	26-May	218	12	71	50	6
41	25-May	214	9	72	58	5
42	22-May	205	2	35	48	1
43	21-May	206	4	43	41	2
44	20-May	205	4	37	51	2
45	19-May	204	4	29	39	2
46	18-May	196	3	30	50	2
47	15-May	201	3	41	49	2
48	14-May	209	7	38	43	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	2,603c	40c	1.51
22-Jul	2,643c	122c	4.40
21-Jul	2,764c	66c	2.31
17-Jul	2,830c	53c	1.84
16-Jul	2,883c	103c	3.46
15-Jul	2,986c	42c	1.42
14-Jul	2,945c	111c	3.62
13-Jul	3,055c	165c	5.71
10-Jul	2,890c	7c	0.24
09-Jul	2,897c	82c	2.89
08-Jul	2,816c	123c	4.57
07-Jul	2,693c	26c	0.96
06-Jul	2,719c	5c	0.19
02-Jul	2,724c	2c	0.08
30-Jun	2,726c	51c	1.90
29-Jun	2,675c	37c	1.39
26-Jun	2,639c	6c	0.23
25-Jun	2,645c	47c	1.73
24-Jun	2,691c	17c	0.61
23-Jun	2,708c	9c	0.35
22-Jun	2,698c	165c	6.52
19-Jun	2,533c	192c	8.19
17-Jun	2,342c	25L	0.01
16-Jun	2,341c	45c	1.95
15-Jun	2,297c	18c	0.78
12-Jun	2,279c	70c	3.17
11-Jun	2,209c	54c	2.37
10-Jun	2,262c	0	0

Stock Checklist

Price is below from 52 week high low average: 38%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 12 fund scheme(s) across 6 fund house(s) as of Jul26 · Total value ₹302 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	2	1.34%	+0.20%	177.1
Tata Mutual Fund	2	0.55%	-	124.9
Bandhan Mutual Fund	2	0.05%	-	0
Angel One Mutual Fund	2	0.00%	-	0
Mirae Asset Mutual Fund	2	0.00%	-	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Hikal Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements